Literature DB >> 6361960

Nosocomial infections due to Pseudomonas aeruginosa: review of recent trends.

A Cross, J R Allen, J Burke, G Ducel, A Harris, J John, D Johnson, M Lew, B MacMillan, P Meers.   

Abstract

The role of Pseudomonas aeruginosa in nosocomial infections occurring since 1975 is reviewed. Data from the National Nosocomial Infections Study conducted by the Centers for Disease Control, from individual medical centers, and from the literature were used to compare the relative frequency of occurrence of nosocomial infection caused by P. aeruginosa with that of infection caused by other gram-negative bacilli. The relative frequency of P. aeruginosa as a nosocomial pathogen has increased, although wide variations are seen among individual medical centers. P. aeruginosa continues to be a major pathogen among patients with immunosuppression, cystic fibrosis, malignancy, and trauma. While Staphylococcus aureus has become the predominant pathogen in some large burn centers, P. aeruginosa is the most important gram-negative pathogen. Periodic review of the epidemiology of P. aeruginosa infection is warranted in view of the changing incidence of infection caused by this organism.

Entities:  

Mesh:

Year:  1983        PMID: 6361960     DOI: 10.1093/clinids/5.supplement_5.s837

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  52 in total

1.  Commercial mushrooms and bean sprouts are a source of Pseudomonas aeruginosa.

Authors:  Barry Curran; J Alun W Morgan; David Honeybourne; Christopher G Dowson
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

2.  The myeloid differentiation factor 88 is dispensable for the development of a delayed host response to Pseudomonas aeruginosa lung infection in mice.

Authors:  M R Power; J S Marshall; M Yamamoto; S Akira; T-J Lin
Journal:  Clin Exp Immunol       Date:  2006-11       Impact factor: 4.330

Review 3.  Antimicrobial agent therapy for Pseudomonas aeruginosa.

Authors:  J A Korvick; V L Yu
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

4.  Isolation and characterization of a transposon-induced cytotoxin-deficient mutant of Pseudomonas aeruginosa.

Authors:  L H Bopp; A L Baltch; M C Hammer; M A Franke; R P Smith; F Lutz
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

5.  Alginate lyase promotes diffusion of aminoglycosides through the extracellular polysaccharide of mucoid Pseudomonas aeruginosa.

Authors:  R A Hatch; N L Schiller
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

Review 6.  Evolving epidemiology of Pseudomonas aeruginosa infections.

Authors:  A S Cross
Journal:  Eur J Clin Microbiol       Date:  1985-04       Impact factor: 3.267

7.  Purification and vaccine potential of Klebsiella capsular polysaccharides.

Authors:  S J Cryz; E Fürer; R Germanier
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

Review 8.  Pseudomonas aeruginosa biofilms in disease.

Authors:  Lawrence R Mulcahy; Vincent M Isabella; Kim Lewis
Journal:  Microb Ecol       Date:  2013-10-06       Impact factor: 4.552

9.  Protection against fatal Klebsiella pneumoniae burn wound sepsis by passive transfer of anticapsular polysaccharide.

Authors:  S J Cryz; E Fürer; R Germanier
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

10.  Genetic exchange of determinants for capsular polysaccharide biosynthesis between Klebsiella pneumoniae strains expressing serotypes K2 and K21a.

Authors:  I Ofek; K Kabha; A Athamna; G Frankel; D J Wozniak; D L Hasty; D E Ohman
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.